View Post

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment

In In The News by Barbara Jacoby

From: UC San Diego Health Sciences News New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment Low levels of two genes predicts positive response to chemotherapy and longer survival times Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs …

View Post

Cancer study: Genomes may predict aspirin’s benefits

In In The News by Barbara Jacoby

By: Shari Rudavsky From: usatoday.com Doctors have known for a while that aspirin and other non-steroidal anti-inflammatory drugs, known as NSAIDs, may help protect some people against colorectal cancer. They also have known that not everyone can benefit. But they haven’t known how to separate those who will benefit from those who won’t. An article in this week’s Journal of …

View Post

Link Found Between Cancer Diagnosis, Stroke Risk

In In The News by Barbara Jacoby

By: Robert Preidt From: HealthDay As published on: usnews.com Newly diagnosed cancer patients are at increased risk for stroke in the months after they find out they have the disease. And the risk of stroke is higher among those with more aggressive cancer, a new study says. The findings come from an analysis of Medicare claims submitted between 2001 and …

Cancer-Detecting Yogurt Could Replace Colonoscopies

In In The News by Barbara Jacoby

Engineered yogurt bacteria could make detecting colorectal cancer and other diseases as simple as a pregnancy test. A spoonful of yogurt could soon offer a cheap and simple way to screen for colorectal cancer. Sangeeta Bhatia, a professor at MIT, is working to replace costly and uncomfortable colonoscopies and MRIs with a helping of yogurt followed by a urine test—a …

Amgen colorectal cancer drug gains U.S. approval for wider use

In In The News by Barbara Jacoby

By: By Alex Wayne, Bloomberg News From: chicagotribune.com Amgen Inc. won expanded U.S. approval for its drug Vectibix as an initial treatment in patients with a type of advanced colorectal cancer who first undergo genetic screening. The drug was cleared by the Food and Drug Administration as an initial treatment in conjunction with chemotherapy for patients whose tumors have a …

Doctors Say Second Most Deadly Cancer is Preventable

In In The News by Barbara Jacoby

The month of March has been proclaimed as Colorectal Cancer Awareness Month, and doctors are taking the time to speak out about preventative measures. Colon cancer is the number two cause of cancer-related deaths in both the country and the state, but doctors say it doesn’t have to be deadly at all. “Colon cancer is actually preventable so screening is …